Bulgaria vs Denmark: HIV/AIDS deaths averted by antiretroviral therapy
Bulgaria
141.97 deaths
in 2024
Denmark
129.29 deaths
in 2024
Bulgaria rank
118th
Denmark rank
121st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Bulgaria
- Denmark
How they compare
Bulgaria currently reports 141.97 deaths against 129.29 deaths in Denmark, a difference of 12.68 deaths.
That makes Bulgaria's figure about 1.1 times Denmark's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Denmark ahead.
Bulgaria ranks 118th and Denmark ranks 121st of 157 countries.
Denmark has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Bulgaria | Denmark | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.04 deaths | 64.92 deaths | 63.88 deaths | Denmark |
| 2000s | 26.77 deaths | 230.44 deaths | 203.67 deaths | Denmark |
| 2010s | 69.6 deaths | 196.83 deaths | 127.23 deaths | Denmark |
| 2020s | 128.47 deaths | 141.56 deaths | 13.09 deaths | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Bulgaria or Denmark?
- Bulgaria, at 141.97 deaths against 129.29 deaths in Denmark as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Bulgaria and Denmark?
- 12.68 deaths, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Denmark?
- 35 years are reported by both, from 1990 to 2024.
- How do Bulgaria and Denmark rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Bulgaria ranks 118th and Denmark ranks 121st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.